Artemis - Breast Cancer Newsletter



	Many Women Who Survived Childhood Cancer Do Not Undergo Recommended Breast Cancer Screening Tinkering with the Circadian Clock Can Suppress Cancer Growth Early Mammograms May Have Net Harm in Some BRCA Mutation Carriers Hispanic Women and Breast Cancer Genetic 'Hotspot' for Breast Cancer Risk in Asian Women Study Finds High Level of Medical Mistrust Among Minority Women Impacts Quality of Healthcare New Guidelines Emphasize Use of Breast MRI to Supplement Standard Imaging Multivitamin Use May Offer No Cancer Reduction Benefit in Postmenopausal Women New Genomic Test Can Personalize Breast Cancer Treatment Study Finds Pregnancy Has No Impact on Breast Cancer Survival But Can Delay Treatment, Diagnosis 19% of Women Do Not Receive Recommended Radiation after Mastectomy Statin Therapy Ineffective in Breast Cancer Prevention

Breast Cancer Risk Rapidly Declines after Women Stop Taking Postmenopausal Combined Hormone Therapy

Women who stopped taking the postmenopausal hormone combination of estrogen plus progestin experienced a marked decline in breast cancer risk which was unrelated to mammography utilization change, according to a study from the Women's Health Initiative led by a Los Angeles Biomedical Research Institute (LA BioMed) investigator that was published in The New England Journal of Medicine.

"These findings support the hypothesis that the recent reduction in breast cancer incidence in the United States is predominantly related to a decrease in combined estrogen plus progestin use," said Rowan T. Chlebowski, M.D., Ph.D., a LA BioMed chief investigator and lead author for the study.

Avon Breast Cancer Crusade - AVON the company for women

This website is supported in part by an unrestricted educational grant provided by Avon